Towards non-invasive monitoring of pathogen-host interactions during Candida albicans biofilm formation using in vivo bioluminescence

Cellular Microbiology

Volumn 16, Issue 1, 2014, Pages 115-130

  Vande Velde, Greetje ^a   Kucharíková, Soňa ^b   Schrevens, Sanne ^b   Himmelreich, Uwe ^a   Van Dijck, Patrick ^b  

^a DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; COELENTERAZINE; UNCLASSIFIED DRUG;

ANTIFUNGAL RESISTANCE; ARTICLE; BIOFILM; BIOLUMINESCENCE; CANDIDA ALBICANS; CANDIDIASIS; CATHETER; FUNGAL VIRULENCE; FUNGUS HYPHAE; GROWTH CURVE; HOST PATHOGEN INTERACTION; IN VITRO STUDY; IN VIVO STUDY; MORPHOGENESIS; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CANDIDA ALBICANS; MUS MUSCULUS; RODENTIA;

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; CATHETER-RELATED INFECTIONS; CYTOLOGICAL TECHNIQUES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HOST-PATHOGEN INTERACTIONS; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MICROBIOLOGICAL TECHNIQUES; RATS, SPRAGUE-DAWLEY;

EID: 84890248470     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12184     Document Type: Article

References (53)

1. Al-Fattani, M.A., and Douglas, L.J. (2004) Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 48: 3291-3297.
2. Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., and Pitula, A. (2004) Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72: 6023-6031.
3. Badr, C.E., and Tannous, B.A. (2011) Bioluminescence imaging: progress and applications. Trends Biotechnol 29: 624-633.
4. Baillie, G.S., and Douglas, L.J. (1999) Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 48: 671-679.
5. Bink, A., Kucharíková, S., Neirinck, B., Vleugels, J., Van Dijck, P., Cammue, B.P., and Thevissen, K. (2012) The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. J Infect Dis 206: 1790-1797.
6. Biswas, S., Van Dijck, P., and Datta, A. (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71: 348-376.
7. Blankenship, J.R., and Mitchell, A.P. (2006) How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9: 588-594.
8. Brock, M. (2012) Application of bioluminescence imaging for in vivo monitoring of fungal infections. Int J Microbiol 2012: 956794.
9. Carlon, M., Toelen, J., Van der Perren, A., Vandenberghe, L.H., Reumers, V., Sbragia, L., etal. (2010) Efficient gene transfer into the mouse lung by fetal intratracheal injection of rAAV2/6.2. Mol Ther 18: 2130-2138.
10. Chen, S.C., Playford, E.G., and Sorrell, T.C. (2010) Antifungal therapy in invasive fungal infections. Curr Opin Pharmacol 10: 522-530.
11. Contag, C.H., Contag, P.R., Mullins, J.I., Spilman, S.D., Stevenson, D.K., and Benaron, D.A. (1995) Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18: 593-603.
12. d'Enfert, C., Vecchiarelli, A., and Brown, A.J.P. (2010) Bioluminescent fungi for real-time monitoring of fungal infections. Virulence 1: 174-176.
13. Donat, S., Hasenberg, M., Schafer, T., Ohlsen, K., Gunzer, M., Einsele, H., etal. (2012) Surface display of Gaussia princeps luciferase allows sensitive fungal pathogen detection during cutaneous aspergillosis. Virulence 3: 51-61.
14. Douglas, L.J. (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 30-36.
15. Doyle, T.C., Nawotka, K.A., Kawahara, C.B., Francis, K.P., and Contag, P.R. (2006) Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene. Microb Pathog 40: 82-90.
16. Eggimann, P., Garbino, J., and Pittet, D. (2003a) Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3: 685-702.
17. Eggimann, P., Garbino, J., and Pittet, D. (2003b) Management of Candida species infections in critically ill patients. Lancet Infect Dis 3: 772-785.
18. Enjalbert, B., Rachini, A., Vediyappan, G., Pietrella, D., Spaccapelo, R., Vecchiarelli, A., etal. (2009) A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections. Infect Immun 77: 4847-4858.
19. Enoch, D.A., Ludlam, H.A., and Brown, N.M. (2006) Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 55: 809-818.
20. Fisher, M.C., Henk, D.A., Briggs, C.J., Brownstein, J.S., Madoff, L.C., McCraw, S.L., and Gurr, S.J. (2012) Emerging fungal threats to animal, plant and ecosystem health. Nature 484: 186-194.
21. Gahan, C.G. (2012) The bacterial lux reporter system: applications in bacterial localisation studies. Curr Gene Ther 12: 12-19.
22. Gillum, A.M., Tsay, E.Y., and Kirsch, D.R. (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E.coli pyrF mutations. Mol Gen Genet 198: 179-182.
23. Giri, S., and Kindo, A.J. (2012) A review of Candida species causing blood stream infection. Indian J Med Microbiol 30: 270-278.
24. Hawser, S.P., and Douglas, L.J. (1995) Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 39: 2128-2131.
25. Hutchens, M., and Luker, G.D. (2007) Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol 9: 2315-2322.
26. Kim, J., and Sudbery, P. (2011) Candida albicans, a major human fungal pathogen. J Microbiol 49: 171-177.
27. Kucharíková, S., Tournu, H., Lagrou, K., Van Dijck, P., and Bujdakova, H. (2011) Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol 60: 1261-1269.
28. Kucharíková, S., Tournu, H., Holtappels, M., Van Dijck, P., and Lagrou, K. (2010) In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis. Antimicrob Agents Chemother 54: 4474-4475.
29. Kucharíková, S., Sharma, N., Spriet, I., Maertens, J., Van Dijck, P., and Lagrou, K. (2013) Activity of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model. Antimicrob Agents Chemother 57: 2365-2368.
30. Lazzell, A.L., Chaturvedi, A.K., Pierce, C.G., Prasad, D., Uppuluri, P., and Lopez-Ribot, J.L. (2009) Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother 64: 567-570.
31. Lewis, R.E., Kontoyiannis, D.P., Darouiche, R.O., Raad, I.I., and Prince, R.A. (2002) Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 46: 3499-3505.
32. Mah, T.F., and O'Toole, G.A. (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
33. Nailis, H., Coenye, T., Van Nieuwerburgh, F., Deforce, D., and Nelis, H.J. (2006) Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol 7: 25.
34. Nett, J., and Andes, D. (2006) Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 9: 340-345.
35. Nikawa, H., Nishimura, H., Yamamoto, T., Hamada, T., and Samaranayake, L.P. (1996) The role of saliva and serum in Candida albicans biofllm formation on denture acrylic surfaces. Microbial Ecology in Health and Disease 9: 35-48.
36. Nobile, C.J., and Mitchell, A.P. (2005) Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15: 1150-1155.
37. Nobile, C.J., Andes, D.R., Nett, J.E., Smith, F.J., Jr, Yue, F., Phan, Q.-T., etal. (2006) Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2: e63.
38. Nucci, M., and Marr, K.A. (2005) Emerging fungal diseases. Clin Infect Dis 41: 521-526.
39. Pemán, J., and Salavert, M. (2012) Epidemiología general de la enfermedad fúngica invasora. Enferm Infecc Microbiol Clin 30: 90-98.
40. Pfaller, M.A., and Diekema, D.J. (2010) Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 36: 1-53.
41. Ramage, G., Bachmann, S., Patterson, T.F., Wickes, B.L., and Lopez-Ribot, J.L. (2002) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49: 973-980.
42. Řičicová, M., Kucharíková, S., Tournu, H., Hendrix, J., Bujdakova, H., Van Eldere, J., etal. (2010) Candida albicans biofilm formaton in a new in vivo rat model. Microbiology 156: 909-919.
43. Schinabeck, M.K., Long, L.A., Hossain, M.A., Chandra, J., Mukherjee, P.K., Mohamed, S., and Ghannoum, M.A. (2004) Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48: 1727-1732.
44. Shimomura, O., Kishi, Y., and Inouye, S. (1993) The relative rate of aequorin regeneration from apoaequorin and coelenterazine analogues. Biochem J 296 (Part 3): 549-551.
45. Sjolinder, H., and Jonsson, A.B. (2007) Imaging of disease dynamics during meningococcal sepsis. PLoS ONE 2: e241.
46. Staab, J.F., Ferrer, C.A., and Sundstrom, P. (1996) Developmental expression of a tandemly repeated, proline-and glutamine-rich amino acid motif on hyphal surfaces on Candida albicans. J Biol Chem 271: 6298-6305.
47. Sudbery, P.E. (2011) Growth of Candida albicans hyphae. Nat Rev Microbiol 9: 737-748.
48. Tannous, B.A., Kim, D.E., Fernandez, J.L., Weissleder, R., and Breakefield, X.O. (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11: 435-443.
49. Vande Velde, G., Kucharikova, S., Dijck, P.V., and Himmelreich, U. (2013) Bioluminescence imaging of fungal biofilm development in live animals. Methods Mol Biol 1098, chapter 13. (in press)
50. Vassel, N., Cox, C.D., Naseem, R., Morse, V., Evans, R.T., Power, R.L., etal. (2012) Enzymatic activity of albumin shown by coelenterazine chemiluminescence. Luminescence 27: 234-241.
51. Warnock, D.W. (2006) Fungal diseases: an evolving public health challenge. Med Mycol 44: 697-705.
52. Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P., and Edmond, M.B. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309-317.
53. Zhao, H., Doyle, T.C., Wong, R.J., Cao, Y., Stevenson, D.K., Piwnica-Worms, D., and Contag, C.H. (2004) Characterization of coelenterazine analogs for measurements of Renilla luciferase activity in live cells and living animals. Mol Imaging 3: 43-54.